Microalbumin Urine Test (ACR) Explained: Normal Range, Early Kidney Damage & Diabetes Risk (India 2026) | माइक्रोएल्ब्यूमिन टेस्ट गाइड
Microalbumin Urine Test (ACR) Explained: Normal Range, Early Kidney Damage, Diabetes & Hypertension Risk (India 2026)
माइक्रोएल्ब्यूमिन टेस्ट (ACR) गाइड: नॉर्मल रेंज, किडनी की शुरुआती क्षति, डायबिटीज़ और हाई BP का खतरा
The microalbumin urine test is one of the most important — and most underutilised — tests in Indian healthcare. It detects kidney damage 5–10 years before creatinine rises, at a stage when the damage is still largely reversible. India has over 8 million people on dialysis or approaching end-stage kidney disease — the majority from diabetic and hypertensive kidney disease. Almost all of these patients had elevated microalbumin for years before anyone checked it. This test costs less than ₹300 and takes one urine sample. Understanding your ACR result — and acting on it early — can prevent dialysis.
If your doctor also ordered Serum Creatinine or HbA1c alongside, see those guides too. For reading lab reports generally, see our beginner's guide to blood test reports.
माइक्रोएल्ब्यूमिन टेस्ट creatinine बढ़ने से 5–10 साल पहले किडनी क्षति का पता लगाता है। भारत में 8 मिलियन लोग डायलिसिस पर — अधिकांश में यह परीक्षण समय पर नहीं हुआ। ₹300 से कम लागत, एक मूत्र नमूना। Table of Contents / विषय सूची
What Is Microalbumin? / माइक्रोएल्ब्यूमिन क्या है?
Albumin is the most abundant protein in blood plasma — synthesised by the liver, it plays crucial roles in maintaining blood oncotic pressure, transporting hormones and drugs, and buffering pH. Normally, the glomerular filtration barrier in the kidneys is highly selective — it prevents large proteins like albumin (molecular weight ~69,000 Da) from passing into the urine filtrate. Any albumin that does pass the glomerulus is largely reabsorbed by the proximal tubule. As a result, normal urine contains virtually no albumin — less than 30 mg per gram of creatinine.
When the glomerular basement membrane is damaged by diabetes, hypertension, or other conditions, its selectivity is lost — albumin begins leaking into the urine. Initially in very small amounts (30–300 mg/g) — called microalbuminuria. As damage progresses, larger amounts leak (above 300 mg/g) — called macroalbuminuria or proteinuria. Routine urine dipstick tests (Urine Routine Examination) detect protein only at concentrations above 300 mg/g — meaning they completely miss microalbuminuria. The microalbumin test is specifically designed to detect this sub-threshold albumin leak.
Albumin एक बड़ा रक्त प्रोटीन है जो सामान्यतः मूत्र में नहीं जाता। जब glomerular barrier क्षतिग्रस्त होती है → albumin मूत्र में रिसता है। 30–300 mg/g = microalbuminuria। Routine dipstick: >300 mg/g तक नहीं पकड़ता — microalbuminuria पूरी तरह छूट जाती है।- Stage 1 (Normoalbuminuria: ACR <30 mg/g): Kidneys appear normal on all tests. May have hyperfiltration (glomeruli working overtime) — not yet detectable as damage.
- Stage 2 (Microalbuminuria: ACR 30–300 mg/g): Early glomerular damage — the critical intervention window. Tight blood sugar control, aggressive BP control (below 130/80), and RAAS blockade (ACE inhibitors or ARBs) at this stage can reverse microalbuminuria in up to 30–50% of patients. The remaining 50–70% can be stabilised and prevented from progressing.
- Stage 3 (Macroalbuminuria/Proteinuria: ACR >300 mg/g): Significant established nephropathy. Progression to kidney failure is more likely but can still be slowed substantially. Creatinine begins rising. Dialysis planning may begin at this stage.
- Stage 4–5 (Advanced CKD/End-stage): GFR falling progressively. By the time creatinine is markedly elevated, over 50% of nephrons are permanently destroyed.
Normal Range — ACR & 24-Hour Urine Albumin
| Category | ACR (mg/g or mg/mmol) | 24-hr Urine Albumin | Clinical Significance | Action |
|---|---|---|---|---|
| Normoalbuminuria सामान्य |
<30 mg/g <3.4 mg/mmol |
<30 mg/day | No significant albumin leak. Kidneys appear healthy. | Annual recheck for diabetics and hypertensives. Maintain BP <130/80, HbA1c <7%. |
| Microalbuminuria प्रारंभिक किडनी क्षति (KDIGO: A2 — Moderately Increased) |
30–300 mg/g 3.4–33.9 mg/mmol |
30–300 mg/day | Early glomerular damage. No symptoms. Creatinine still normal. Most important window for reversing kidney damage. | Confirm on 2 of 3 samples over 3–6 months. Start/optimise ACE inhibitor or ARB. Aggressive BP control <130/80. Tight glucose control. Low-protein diet (if nephrologist advises). 3-monthly ACR monitoring. |
| Macroalbuminuria महत्वपूर्ण किडनी क्षति (KDIGO: A3 — Severely Increased) |
>300 mg/g >33.9 mg/mmol |
>300 mg/day | Significant established nephropathy. Creatinine may be rising. Oedema may develop. Higher risk of progression to dialysis. | Nephrologist consultation mandatory. Check eGFR + serum creatinine. Maximise RAAS blockade. Consider SGLT2 inhibitor (Empagliflozin, Dapagliflozin). Dietary sodium and protein restriction. |
| Nephrotic range proteinuria | >3,000–3,500 mg/g | >3.5 g/day | Severe protein loss. Oedema, low serum albumin, hyperlipidaemia. Nephrotic syndrome. | Urgent nephrologist referral. Possible kidney biopsy. Diuretics for oedema. Statins for hyperlipidaemia. |
Why ACR Is Better Than Albumin Alone
The 24-hour urine albumin collection (patient collects all urine over exactly 24 hours in a large container) was the historical gold standard — it gives total albumin excretion per day. However: 24-hour collections are inconvenient, prone to collection errors (missed voids), and require refrigeration during collection. The spot urine ACR correlates very closely (r >0.90) with 24-hour albumin and has replaced 24-hour collection as the preferred method in all major Indian (RSSDI, CSN) and international (ADA, KDIGO) guidelines. Always use ACR — not random urine albumin alone — for clinical decisions. The first morning void (before any activity) gives the most consistent ACR values.
Indian labs report ACR in two different units depending on whether creatinine is measured in mg/dL (giving ACR in mg/g) or µmol/L (giving ACR in mg/mmol). The normal range differs between units:
- Normal: <30 mg/g OR <3.4 mg/mmol
- Microalbuminuria: 30–300 mg/g OR 3.4–33.9 mg/mmol
- Macroalbuminuria: >300 mg/g OR >33.9 mg/mmol
Causes of Elevated Microalbumin / हाई माइक्रोएल्ब्यूमिन के कारण
Diabetic nephropathy is the most common cause of microalbuminuria in India — affecting approximately 40% of all diabetic patients over a lifetime. In Type 2 diabetes (by far the most common form in India), microalbuminuria may already be present at the time of diabetes diagnosis in 5–10% of patients — because T2DM is often undiagnosed for years before discovery. All newly diagnosed T2DM patients in India must have an immediate baseline ACR test. Pathophysiology: hyperglycaemia → glycation of glomerular basement membrane proteins → increased glomerular permeability → albumin leakage.
Uncontrolled hypertension damages the glomerular filtration barrier through mechanical stress on the glomerular capillary walls. Hypertensive nephropathy is the second most common cause of end-stage kidney disease in India. Microalbuminuria in a hypertensive patient is both a marker of kidney damage AND an independent cardiovascular risk marker — patients with microalbuminuria + hypertension have significantly higher risk of heart attack and stroke. Target BP for microalbuminuric hypertensives: below 130/80 mmHg (or below 125/75 in some guidelines with ACR >300).
Microalbuminuria is not only a kidney marker — it is a systemic marker of endothelial dysfunction and increased cardiovascular risk. Multiple large studies show microalbuminuria in the general population (including non-diabetics, non-hypertensives) is associated with 2–3× higher risk of heart attack, stroke, and cardiovascular mortality. This is why some Indian cardiologists order urine ACR in high-risk patients (smokers, obese, family history of CV disease, metabolic syndrome) even in the absence of diabetes or hypertension.
These cause temporary albumin elevation that resolves with the underlying cause — not diabetic nephropathy:
- Vigorous exercise in the previous 24 hours
- Urinary tract infection (UTI)
- High fever (>38.5°C)
- Menstruation in women — do not collect during periods
- Severe dehydration or extreme heat
- Acute uncontrolled hypertension (home BP crisis)
- Recent high-protein meal
- Congestive heart failure exacerbation
- Recent surgery or trauma
Diabetic Kidney Disease — Stage by Stage
Diabetic kidney disease (DKD) — historically called diabetic nephropathy — progresses through five stages. Understanding the stage helps patients understand the urgency and reversibility of their condition:
मधुमेह गुर्दा रोग (DKD) पाँच चरणों में बढ़ता है। Stage पता होने से रोगी हस्तक्षेप की तात्कालिकता और उलटाव की संभावना समझ सकते हैं।| Stage | GFR (eGFR) | ACR / Albumin | Creatinine | Symptoms | Reversibility |
|---|---|---|---|---|---|
| Stage 1 Hyperfiltration |
>90 mL/min (↑) | Normal <30 | Normal | None | Fully reversible with tight glycaemic control |
| Stage 2 Silent damage |
60–89 mL/min | Normal <30 | Normal | None — silent | Largely reversible |
| Stage 3 Microalbuminuria ← KEY WINDOW |
30–89 mL/min | 30–300 mg/g | Normal or borderline high | None typically — may have mild BP rise | Partially reversible (30–50%) — ACE/ARB + BP + glucose control can reverse |
| Stage 4 Macroalbuminuria |
15–59 mL/min (↓) | >300 mg/g | Rising ↑ | Oedema, frothy urine, fatigue, anaemia | Progression can be slowed — not reversed |
| Stage 5 Kidney failure (ESRD) |
<15 mL/min | Very high | Very high ↑↑ | Severe — uraemia symptoms, dialysis needed | Not reversible — dialysis or transplant |
Protecting Your Kidneys — What Actually Works
ACE inhibitors (Ramipril, Enalapril, Lisinopril) and ARBs (Losartan, Telmisartan, Valsartan) are the cornerstone of diabetic nephropathy treatment — beyond their blood pressure lowering effect, they specifically reduce glomerular pressure and intraglomerular hypertension, directly reducing albumin leakage. The UKPDS and RENAAL trials demonstrated ACE/ARB therapy reduces the rate of progression from microalbuminuria to macroalbuminuria by 30–50% and from macroalbuminuria to end-stage kidney disease by ~25%. In Indian T2DM with microalbuminuria: start ACE inhibitor or ARB even if BP is normal — the renoprotective effect is independent of blood pressure lowering. Never use both ACE inhibitor AND ARB together — dual RAAS blockade increases hyperkalaemia and acute kidney injury risk.
SGLT2 inhibitors (Empagliflozin, Dapagliflozin, Canagliflozin) represent the most significant advance in diabetic kidney disease treatment since ACE inhibitors. The CREDENCE and DAPA-CKD trials showed SGLT2 inhibitors reduce progression of DKD by 30–40% beyond ACE/ARB therapy — independently of their glucose-lowering effects. Mechanism: reduce glomerular hyperfiltration by restoring tubuloglomerular feedback; reduce proximal tubule oxygen consumption; anti-inflammatory and anti-fibrotic effects. Now recommended in Indian and international guidelines for all T2DM patients with microalbuminuria or macroalbuminuria (eGFR above 25 mL/min). Available as generics in India at affordable cost. Discuss with your diabetologist or nephrologist.
For all patients with microalbuminuria, the BP target is below 130/80 mmHg (some guidelines <125/75 for macroalbuminuria). In India, where hypertension is both a cause and accelerator of kidney disease, many diabetic patients with microalbuminuria have uncontrolled BP. Home BP monitoring is essential — office BP readings underestimate the problem. A digital BP monitor at home allowing twice-daily readings is now standard of care for all diabetic or hypertensive patients with microalbuminuria. Share the BP log with the nephrologist at every visit. .
Tight glycaemic control is the most effective intervention for preventing microalbuminuria from developing in the first place, and for reversing it when caught early. Target: HbA1c below 7% (below 6.5% if safely achievable without hypoglycaemia) in younger T2DM patients without established complications. The DCCT trial in T1DM and UKPDS in T2DM demonstrated that intensive glucose control reduces the risk of developing microalbuminuria by ~39% and slows progression once microalbuminuria is present. In India, however, aggressive HbA1c targets must be balanced against hypoglycaemia risk — particularly for elderly patients on sulfonylureas or insulin.
Dietary modifications that help:
- Low-protein diet (0.8 g/kg/day) — reduces hyperfiltration; consult nephrologist before restricting (too much restriction causes malnutrition)
- Low sodium (below 2.3 g/day = <6 g salt) — reduces BP and directly reduces albumin excretion
- Avoid nephrotoxic NSAIDs — ibuprofen, diclofenac, naproxen reduce renal blood flow; acute NSAID use in microalbuminuric patients can precipitate acute kidney injury
- Quit smoking — smoking independently accelerates microalbuminuria progression and reduces ACE inhibitor efficacy
- Weight loss — obesity increases intraglomerular pressure; 5–10% weight loss reduces ACR by 30–50% in obese patients
Annual ACR testing is recommended for:
- All Type 2 diabetes patients — annually from diagnosis
- Type 1 diabetes — annually starting 5 years after diagnosis
- All hypertensives — particularly those with uncontrolled BP
- Patients with metabolic syndrome or central obesity
- Family history of chronic kidney disease or diabetic nephropathy
- All patients on long-term NSAIDs, contrast dye procedures, or other nephrotoxic exposures
- Patients with reduced eGFR — even without diabetes (CKD monitoring)
- Patients already on ACE inhibitors or ARBs — to confirm the medication is working
Test Preparation Checklist / टेस्ट की तैयारी
The urine microalbumin ACR test has specific preparation requirements that directly affect accuracy:
Urine microalbumin ACR परीक्षण की विशिष्ट तैयारी आवश्यकताएं परिणाम की सटीकता को प्रभावित करती हैं।-
Use the first morning urine void — ideally between 6–8 AM. The first morning urine sample is the most concentrated and most consistent for ACR measurement — it has the least day-to-day variability and gives the closest correlation with 24-hour albumin excretion. Random spot urine (any time of day) is acceptable if first morning void is not possible — the ACR corrects for concentration — but first morning void is the gold standard.
-
Do not exercise vigorously for 24 hours before the test. Exercise — particularly intense running, weight training, or HIIT — dramatically increases albumin in urine for 24–48 hours post-exercise (exercise-induced proteinuria). A falsely elevated ACR from exercise is one of the most common causes of a repeat test being normal. Rest the day before for an accurate baseline reading.
-
Do not test during a UTI, fever, or menstruation. Urinary tract infection, fever above 38.5°C, and menstruation all transiently elevate urine albumin. Testing during these conditions gives falsely elevated ACR that may not represent kidney disease. Wait until the UTI is fully treated, fever has resolved for 48 hours, and menstruation is complete before collecting the sample.
-
Collect mid-stream urine in a sterile container. Mid-stream clean-catch urine reduces contamination from genital flora and epithelial cells. Clean the urethral opening before collection. Discard the initial urine stream, collect the middle portion in the container, then stop. Do not contaminate the inside of the container with fingers or surroundings. Deliver to the lab within 2 hours (refrigerate if delayed).
-
Continue all medications — including ACE inhibitors, ARBs, diabetes and BP drugs. The ACR test reflects your kidney status on your current medication regimen — which is exactly what your nephrologist needs to see. Do not stop any medication before the test. If you are already on an ACE inhibitor or ARB, the ACR shows whether the treatment is adequately reducing albumin leakage.
-
Always order alongside serum creatinine and eGFR. ACR and eGFR (calculated from serum creatinine) together give a complete picture of kidney health — ACR tells you about glomerular leakage (type and stage of damage); eGFR tells you about remaining kidney function (how much filtration capacity remains). The KDIGO 2022 staging system uses both ACR and eGFR together to classify CKD severity. Never interpret microalbumin without the creatinine context.
-
Confirm elevated ACR on 2 out of 3 samples before starting new medications. Before your nephrologist starts an ACE inhibitor or ARB specifically for microalbuminuria, the elevation should be confirmed on at least 2 of 3 separate morning urine samples collected over 3–6 months — to exclude transient causes. For already-established diabetic nephropathy (repeat elevated ACR with rising creatinine), this confirmation step is not required before treatment.
✅ Book Urine Microalbumin (ACR) Test — Home Urine Sample Collection
Book the complete Kidney Function Screen — Urine ACR (Microalbumin/Creatinine Ratio) + Serum Creatinine + eGFR — together for the most clinically useful kidney damage assessment. Remember: first morning urine sample for best ACR accuracy:
Affiliate link: I may earn a small commission at no extra cost to you. Microalbumin testing is available at government hospital nephrology and diabetes OPDs across India. Always have elevated ACR results interpreted by a qualified nephrologist or diabetologist alongside serum creatinine, eGFR, blood pressure, and HbA1c — never in isolation.
Microalbumin testing सरकारी अस्पतालों के nephrology/diabetes OPD में उपलब्ध। elevated ACR पर nephrologist से creatinine, eGFR, BP और HbA1c के साथ परिणाम समझें। Home Kidney & BP Monitoring Tools
Two essential home monitoring tools for patients with microalbuminuria — a digital BP monitor (BP control below 130/80 is the most important treatment goal) and urine reagent strips for monitoring protein in urine between ACR tests. Always consult your nephrologist for your specific BP targets and monitoring schedule.
For patients with microalbuminuria, achieving and maintaining blood pressure below 130/80 mmHg is the single most important modifiable factor to prevent progression to kidney failure. Hypertension significantly accelerates diabetic nephropathy — even single-digit reductions in blood pressure translate to clinically meaningful reductions in albuminuria and GFR decline. Home BP monitoring with twice-daily readings (morning before medication + evening) provides far more clinically useful data than occasional office BP readings. The Dr Morepen BP-02 provides upper-arm cuff measurement — more accurate than wrist monitors for clinical decision-making. Share your home BP log at every nephrologist visit. Target: below 130/80 consistently throughout the day.
View on Amazon IndiaAffiliate link — small commission at no extra cost.
Urine dipstick reagent strips for quick home monitoring of protein (albumin) and glucose in urine. While these strips detect protein only at concentrations above 300 mg/g (missing microalbuminuria — which is why formal ACR testing is essential), they are useful for monitoring: detecting macroalbuminuria (heavy protein >300 mg/g) between formal ACR tests; monitoring for glycosuria (glucose in urine — elevated blood sugar spilling into urine); detecting UTI-associated protein before an ACR test; quick semi-quantitative assessment of proteinuria trend. Important: a negative urine protein on a dipstick does NOT mean microalbuminuria is absent — always use formal ACR for microalbuminuria screening. These strips are a complement to, not a replacement for, laboratory ACR testing.
View on Amazon IndiaAffiliate link — small commission at no extra cost.
Related Tests / संबंधित जांचें
These tests are commonly ordered alongside microalbumin ACR in the kidney and diabetes workup:
Microalbumin ACR के साथ ये जांचें अक्सर करवाई जाती हैं:Frequently Asked Questions / अक्सर पूछे जाने वाले सवाल
An ACR of 45 mg/g is in the microalbuminuria range (30–300 mg/g) — this is called "moderately increased albuminuria" in current KDIGO 2022 terminology. It means there is early glomerular damage with a detectable but still small amount of albumin leaking into the urine. This is the most important finding to act on — you are in the intervention window where damage is still largely reversible. However, a single elevated reading must be confirmed on at least 2 of 3 urine samples collected over 3–6 months before concluding persistent microalbuminuria. A one-time result of 45 mg/g could reflect vigorous exercise, a UTI, fever, or uncontrolled blood pressure on that specific day. If confirmed on repeat testing: consult a nephrologist; check serum creatinine + eGFR; assess blood pressure (target below 130/80); check HbA1c (target below 7%); and discuss starting an ACE inhibitor or ARB with your doctor if not already on one.
उत्तर: ACR 45 mg/g = microalbuminuria — प्रारंभिक किडनी क्षति की intervention window। 3–6 महीनों में 3 में से 2 नमूनों में confirm करें। BP <130/80 + HbA1c <7% + ACE inhibitor/ARB → reversal संभव।Yes — this is precisely the pattern that makes microalbumin testing so valuable, and it should not be dismissed just because creatinine is normal. Creatinine rises only when over 50% of kidney filtration function (nephrons) is already permanently lost. Microalbuminuria with normal creatinine means kidney damage has begun but is still at an early enough stage that creatinine has not yet risen — the majority of nephrons are still functional. This is the ideal time to intervene: with tight blood pressure control (below 130/80), optimised blood sugar control, and ACE inhibitor or ARB therapy, progression can be halted and in 30–50% of patients the microalbuminuria can be reversed entirely. Once creatinine starts rising, we are past this window. Normal creatinine + elevated ACR = early detection success — take it seriously and act.
उत्तर: हाँ — यही सबसे महत्वपूर्ण पैटर्न है। Creatinine केवल 50%+ nephron हानि पर बढ़ता है। Normal creatinine + elevated ACR = early detection — अभी intervene करें। ACE/ARB + BP <130/80 + HbA1c <7% = reversal संभव।No — fasting is not required for the urine microalbumin ACR test. It is a urine test detecting a protein-to-creatinine ratio in urine — food intake does not significantly affect albumin or creatinine excretion in the kidneys. The timing of urine collection is far more important than fasting: the first morning void (collected immediately on waking, before any physical activity) gives the most consistent and accurate ACR results and correlates best with 24-hour albumin excretion. However, avoid intense exercise for 24 hours before testing — exercise significantly elevates urine albumin and can create falsely high ACR readings that suggest kidney disease when none exists.
उत्तर: नहीं — उपवास आवश्यक नहीं। Timing महत्वपूर्ण है: सुबह सोकर उठने के बाद पहला मूत्र (किसी शारीरिक गतिविधि से पहले)। परीक्षण से 24 घंटे पहले तीव्र व्यायाम से बचें।It is definitely not too late — and you should get tested immediately. After 10 years of Type 2 diabetes, the risk of having developed microalbuminuria is significant — approximately 20–30% of T2DM patients have microalbuminuria by 10 years. But even if you have advanced to macroalbuminuria (ACR above 300 mg/g), aggressive treatment with ACE inhibitors or ARBs, SGLT2 inhibitors, BP control below 130/80, and tight HbA1c can substantially slow the rate of progression to kidney failure — even if reversal is less likely at this stage. The UKPDS showed that improving glycaemic control at any stage reduces the rate of nephropathy progression. And if you are fortunate enough to still be in the microalbuminuria range, there is still a real chance of reversal. Get the test today: ACR + serum creatinine + eGFR. Take the results to your diabetologist or nephrologist immediately.
उत्तर: बिल्कुल नहीं — अभी परखें। 10 साल T2DM के बाद 20–30% में microalbuminuria। ACE/ARB + SGLT2 inhibitor + BP control + HbA1c किसी भी Stage पर progression धीमा करते हैं। आज ही: ACR + creatinine + eGFR।Yes — but only at the microalbuminuria stage (ACR 30–300 mg/g), and only with aggressive multi-factorial treatment. Multiple landmark trials have demonstrated reversal (ACR returning to below 30 mg/g) in approximately 30–50% of patients with microalbuminuria who achieve: HbA1c below 7% (tight glycaemic control); blood pressure below 130/80 mmHg; ACE inhibitor or ARB therapy; smoking cessation; weight loss of at least 5–7%; low-protein diet (below 0.8 g/kg/day); avoidance of nephrotoxic drugs (NSAIDs). The combination of SGLT2 inhibitors with ACE/ARB therapy (as recommended in 2020s guidelines) achieves even higher rates of microalbuminuria regression than older approaches. Once microalbuminuria progresses to macroalbuminuria (above 300 mg/g) or the eGFR begins falling, true reversal is less likely — though progression can still be substantially slowed. This is why early detection and early intervention at the microalbuminuria stage is so critical.
उत्तर: हाँ — microalbuminuria (ACR 30–300) stage पर 30–50% में reversal संभव। शर्तें: HbA1c <7% + BP <130/80 + ACE/ARB + SGLT2 inhibitor + वजन घटाना + धूम्रपान बंद। Macroalbuminuria पर reversal कम likely।No — a negative protein on a routine urine dipstick (Urine Routine Examination) does NOT mean kidneys are fine and does NOT rule out microalbuminuria. This is one of the most common and potentially dangerous misconceptions in Indian diabetes management. The routine urine dipstick detects protein only at concentrations above 200–300 mg/g — it completely misses the microalbuminuria range (30–300 mg/g). A person with ACR of 150 mg/g — significantly elevated microalbuminuria indicating early kidney damage — will have a normal negative dipstick protein result on routine urinalysis. This is why the specific microalbumin ACR test is required for kidney screening in diabetics and hypertensives — it is approximately 10 times more sensitive than the routine dipstick for detecting early kidney damage. Never use a negative routine urine test as reassurance about kidney health in a diabetic or hypertensive patient.
उत्तर: नहीं — Routine urine dipstick केवल >200–300 mg/g पर protein detect करता है। ACR 150 mg/g वाला व्यक्ति = normal dipstick। Microalbumin ACR test routinedipstick से ~10 गुना अधिक संवेदनशील है। Diabetic/hypertensive में negative dipstick = किडनी ठीक की गारंटी नहीं।- KDIGO 2022 — CKD Guidelines: KDIGO 2022 Clinical Practice Guideline for CKD Evaluation and Management
- ADA — Diabetes Standards: ADA Standards 2024 — CKD in Diabetes
- RSSDI — India: Research Society for Study of Diabetes in India — Nephropathy Guidelines
⚠️ Medical Disclaimer / चिकित्सा अस्वीकरण
This article is for educational purposes only. Elevated microalbumin ACR results must always be confirmed and interpreted by a qualified nephrologist or diabetologist alongside serum creatinine, eGFR, blood pressure, and HbA1c. Never start or stop ACE inhibitors, ARBs, or SGLT2 inhibitors based on this guide alone. These medications have important monitoring requirements and contraindications that require medical supervision.
यह लेख केवल शैक्षिक उद्देश्यों के लिए है। elevated ACR पर nephrologist से creatinine, eGFR, BP, HbA1c के साथ परिणाम समझें। ACE inhibitor, ARB या SGLT2 inhibitor इस गाइड के आधार पर अकेले शुरू या बंद न करें।
Comments
Post a Comment